Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet HIV; January 2020, Vol. 7 Issue: 1 pe16-e26, 11p
- Subject
- Language
- ISSN
- 24054704; 23523018